-
Something wrong with this record ?
Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases
M. Kwik, S. Hainzl, J. Oppelt, B. Tichy, U. Koller, E. Bernardinelli, M. Steiner, G. Zara, C. Nofziger, S. Weis, M. Paulmichl, S. Dossena, W. Patsch, SM. Soyal
Language English Country Switzerland
Document type Journal Article
Grant support
V344-B24
Austrian Science Fund
E-13/18094_PAT PMU-FFA-14/01/011-SOY
Paracelsus Medical University Salzburg
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
33804860
DOI
10.3390/ijms22073296
Knihovny.cz E-resources
- MeSH
- Transcriptional Activation * MeSH
- Exons MeSH
- Gene Regulatory Networks * MeSH
- HEK293 Cells MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Neurodegenerative Diseases genetics MeSH
- Neurons metabolism MeSH
- Nucleotide Motifs MeSH
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha genetics metabolism MeSH
- Promoter Regions, Genetic * MeSH
- Protein Isoforms genetics metabolism MeSH
- Transcriptome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
The transcriptional regulator peroxisome proliferator activated receptor gamma coactivator 1A (PGC-1α), encoded by PPARGC1A, has been linked to neurodegenerative diseases. Recently discovered CNS-specific PPARGC1A transcripts are initiated far upstream of the reference promoter, spliced to exon 2 of the reference gene, and are more abundant than reference gene transcripts in post-mortem human brain samples. The proteins translated from the CNS and reference transcripts differ only at their N-terminal regions. To dissect functional differences between CNS-specific isoforms and reference proteins, we used clustered regularly interspaced short palindromic repeats transcriptional activation (CRISPRa) for selective endogenous activation of the CNS or the reference promoters in SH-SY5Y cells. Expression and/or exon usage of the targets was ascertained by RNA sequencing. Compared to controls, more differentially expressed genes were observed after activation of the CNS than the reference gene promoter, while the magnitude of alternative exon usage was comparable between activation of the two promoters. Promoter-selective associations were observed with canonical signaling pathways, mitochondrial and nervous system functions and neurological diseases. The distinct N-terminal as well as the shared downstream regions of PGC-1α isoforms affect the exon usage of numerous genes. Furthermore, associations of risk genes of amyotrophic lateral sclerosis and Parkinson's disease were noted with differentially expressed genes resulting from the activation of the CNS and reference gene promoter, respectively. Thus, CNS-specific isoforms markedly amplify the biological functions of PPARGC1A and CNS-specific isoforms and reference proteins have common, complementary and selective functions relevant for neurodegenerative diseases.
Department of Personalized Medicine Humanomed 9020 Klagenfurt Austria
Division of Neuropathology Neuromed Campus Kepler University Hospital 4020 Linz Austria
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019011
- 003
- CZ-PrNML
- 005
- 20240103105128.0
- 007
- ta
- 008
- 210728s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms22073296 $2 doi
- 035 __
- $a (PubMed)33804860
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kwik, Markus $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
- 245 10
- $a Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases / $c M. Kwik, S. Hainzl, J. Oppelt, B. Tichy, U. Koller, E. Bernardinelli, M. Steiner, G. Zara, C. Nofziger, S. Weis, M. Paulmichl, S. Dossena, W. Patsch, SM. Soyal
- 520 9_
- $a The transcriptional regulator peroxisome proliferator activated receptor gamma coactivator 1A (PGC-1α), encoded by PPARGC1A, has been linked to neurodegenerative diseases. Recently discovered CNS-specific PPARGC1A transcripts are initiated far upstream of the reference promoter, spliced to exon 2 of the reference gene, and are more abundant than reference gene transcripts in post-mortem human brain samples. The proteins translated from the CNS and reference transcripts differ only at their N-terminal regions. To dissect functional differences between CNS-specific isoforms and reference proteins, we used clustered regularly interspaced short palindromic repeats transcriptional activation (CRISPRa) for selective endogenous activation of the CNS or the reference promoters in SH-SY5Y cells. Expression and/or exon usage of the targets was ascertained by RNA sequencing. Compared to controls, more differentially expressed genes were observed after activation of the CNS than the reference gene promoter, while the magnitude of alternative exon usage was comparable between activation of the two promoters. Promoter-selective associations were observed with canonical signaling pathways, mitochondrial and nervous system functions and neurological diseases. The distinct N-terminal as well as the shared downstream regions of PGC-1α isoforms affect the exon usage of numerous genes. Furthermore, associations of risk genes of amyotrophic lateral sclerosis and Parkinson's disease were noted with differentially expressed genes resulting from the activation of the CNS and reference gene promoter, respectively. Thus, CNS-specific isoforms markedly amplify the biological functions of PPARGC1A and CNS-specific isoforms and reference proteins have common, complementary and selective functions relevant for neurodegenerative diseases.
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a exony $7 D005091
- 650 12
- $a genové regulační sítě $7 D053263
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a neurodegenerativní nemoci $x genetika $7 D019636
- 650 _2
- $a neurony $x metabolismus $7 D009474
- 650 _2
- $a nukleotidové motivy $7 D059372
- 650 _2
- $a PPARGC1A $x genetika $x metabolismus $7 D000071248
- 650 12
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a protein - isoformy $x genetika $x metabolismus $7 D020033
- 650 12
- $a aktivace transkripce $7 D015533
- 650 _2
- $a transkriptom $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hainzl, Stefan $u EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria
- 700 1_
- $a Oppelt, Jan $u CEITEC-Central European Institute of Technology, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic $u Department of Pathology and Laboratory Medicine, Perlman School of Medicine, University of Pennsylvania, 614 Stellar-Chance Labs, 422 Curie Blvd, Philadelphia, PA 19104-6100, USA
- 700 1_
- $a Tichý, Boris $u CEITEC-Central European Institute of Technology, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic $7 xx0312236
- 700 1_
- $a Koller, Ulrich $u EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria
- 700 1_
- $a Bernardinelli, Emanuele $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
- 700 1_
- $a Steiner, Markus $u Third Medical Department, Cancer Research Institute, Paracelsus Medical University, Cancer Cluster Salzburg, 5020 Salzburg, Austria
- 700 1_
- $a Zara, Greta $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
- 700 1_
- $a Nofziger, Charity $u PharmGenetix GmbH, 5081 Niederalm, Austria
- 700 1_
- $a Weis, Serge $u Division of Neuropathology, Neuromed Campus, Kepler University Hospital, 4020 Linz, Austria
- 700 1_
- $a Paulmichl, Markus $u Department of Personalized Medicine, Humanomed, 9020 Klagenfurt, Austria
- 700 1_
- $a Dossena, Silvia $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
- 700 1_
- $a Patsch, Wolfgang $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
- 700 1_
- $a Soyal, Selma M $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 7 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33804860 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20240103105124 $b ABA008
- 999 __
- $a ok $b bmc $g 1689939 $s 1139457
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 22 $c 7 $e 20210324 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a V344-B24 $p Austrian Science Fund
- GRA __
- $a E-13/18094_PAT PMU-FFA-14/01/011-SOY $p Paracelsus Medical University Salzburg
- LZP __
- $a Pubmed-20210728